Stocks/AMT

AMT three-lens brief

Evidence-based stock research on AMT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$160.06$172.98$199.13

Performance

1W
-2.7%
1M
+2.0%
3M
-8.2%
6M
-6.2%
YTD
-1.5%
1Y
-12.0%
3Y
5Y
AMT · Nightly brief
Watch

Analyst mean target $215.70 — 25% above current (23 analysts). · Debt-to-equity of 439% — balance-sheet-heavy.

  • Analyst mean target $215.70 — 25% above current (23 analysts).
  • Debt-to-equity of 439% — balance-sheet-heavy.

AMT closed at $172.98 (-1.40%) as of 2026-09-11. Market cap: $80.60B. P/E (trailing) 24.2. Price is above the 50-day MA and below the 200-day MA. Positives: analyst mean target $215.70 — 25% above current (23 analysts).. Concerns: debt-to-equity of 439% — balance-sheet-heavy.. Last quarter: Revenue $2.75B, net income $867.50M, free cash flow $2.92B.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on AMT, not one.

A single reasoning model has blind spots it doesn’t know about. We examine AMTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/AMT"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath AMT brief"></iframe>